Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03587844
Title Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

mycosis fungoides

Sezary's disease

Therapies

Brentuximab vedotin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.